If the rapid quantitative detection of target biomarkers in samples can be realized in experimental research, it will undoubtedly provide great convenience for experiments. Ace Therapeutics provides diagnostic kits and reagent development services to promote our clients' in-depth research into cardiovascular diseases.
In recent years, due to the great technological advances in the field of in vitro diagnostics, many new biomarkers of cardiovascular diseases have been applied in clinical practice and play an important role in clinical diagnostics. Depending on the classification, these cardiovascular disease biomarkers can be matched with different assay kits to meet the need for rapid testing in preclinical research.
Fig. 1 Novel diagnostic methods and novel therapies to improve heart failure care. (Frantz S, et al., 2022)
Diagnostic kits are one of the most important technologies for biomarker research in cardiovascular disease. With a high-end technology platform and an experienced research team, Ace Therapeutics can develop different types of diagnostic kits according to the customer's experimental needs.
We can develop a variety of cardiac myosin assay kits for our customers to facilitate new breakthroughs in cardiovascular disease-related research.
We can provide researchers with development services for various cardiovascular cytokine assay kits to support cardiovascular disease research.
We can provide a variety of molecular diagnostic kit solutions for the genetic diagnosis of monogenic cardiovascular diseases or polygenic cardiovascular diseases.
Ace Therapeutics aims to provide diagnostic development services including high-performance IVD reagent development and specialized diagnostic kit solutions. If you are interested in our services, please don't hesitate to contact us.
Copyright © Ace Therapeutics. All rights reserved.